COAG Consultation Regulation Impact Statement - Governance Forum on Consumer Affairs (CAF)
On 3 October 2019, the Department of Industry, Innovation and Science released a Council of Australian Government’s Regulation Impact Statement (RIS) for consultation on appropriate Country of Origin Labelling for Australian complementary medicines.
The RIS considers the tension between regulation of certain complementary medicines manufactured in Australia under one Australian Law and regulated by the Therapeutic Goods Administration; and under the Australian Consumer Law and eligibility requirements for access to the Australian Made, Australian Grown (AMAG) logo when making an origin claim.